Home
Solutions
Products
Pricing
Resources
Request Demo
Start Free
Menu Search Account

LegiStorm

Get LegiStorm App Visit Product Demo Website
» Get LegiStorm App
» Get LegiStorm Pro Free Demo
StateStorm

Weekly Updates

LegiStorm is constantly adding new information on the people, places and reports in our database. In the past week, LegiStorm added:

  • 1865 new people
  • 34 new organizations
  • 622 new photos
  • 1247 job history records for people in our database
  • 518 education records for people in our database
  • 2209 contact addresses, emails and URLs (LinkedIn, Facebook, etc.)
  • 198 new policy reports
  • 12 new trips to our privately funded travel database
  • 921 new personal financial disclosures
  • 27459 new press releases
  • 30 new town halls

Caught Our Eye Rss

» More from Caught Our Eye
» More from our DevBlog

Tax Policy: Pharmaceutical Industry's Use of the Research Tax Credit

  Premium   Download PDF Now (42 pages)
Report Type Reports and Testimonies
Report Date May 13, 1994
Report No. GGD-94-139
Subject
Summary:

In 1991, Congress enacted the research and experimentation tax credit to encourage businesses to do research. GAO estimates that the pharmaceutical industry earned $1.24 billion worth of these tax credits between 1981 and 1990. The industry's credits as a share of the credits earned by all industries rose from four percent in 1981 to 12 percent in 1990. These credits were earned primarily by large companies--those with assets of $250 million or more. The biotechnology sector benefitted very little from the tax credit. The research and experimentation tax credit is difficult for the Internal Revenue Service (IRS) to administer because (1) auditors have to distinguish stages of research, (2) audit issues are often highly technical, and (3) successive proposed regulations cause uncertainty.

« Return to search Government Accountability Office reports

HomeAbout Us Contact UsPrivacy PolicyTerms of UseJoin Us
© LegiStorm
LegiStorm
2101 L St. NW, Suite 300
Washington, DC 20037
(202) 360-4172 / congress@legistorm.com